1. Home
  2. SMWB vs NUVB Comparison

SMWB vs NUVB Comparison

Compare SMWB & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

HOLD

Current Price

$7.18

Market Cap

747.7M

Sector

Technology

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.37

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMWB
NUVB
Founded
2007
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
747.7M
2.9B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SMWB
NUVB
Price
$7.18
$8.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
9
Target Price
$14.38
$10.56
AVG Volume (30 Days)
293.0K
5.6M
Earning Date
02-10-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$275,429,000.00
$26,748,000.00
Revenue This Year
$16.89
$609.55
Revenue Next Year
$13.80
$197.91
P/E Ratio
N/A
N/A
Revenue Growth
14.25
1137.19
52 Week Low
$6.36
$1.54
52 Week High
$17.64
$9.75

Technical Indicators

Market Signals
Indicator
SMWB
NUVB
Relative Strength Index (RSI) 44.29 51.08
Support Level $6.97 $8.04
Resistance Level $7.42 $9.10
Average True Range (ATR) 0.30 0.45
MACD 0.04 -0.19
Stochastic Oscillator 36.09 22.74

Price Performance

Historical Comparison
SMWB
NUVB

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: